Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies

dc.creatorLi, Ying
dc.creatorLiu, Shanglong
dc.creatorZhang, Shuchao
dc.creatorJu, Qiang
dc.creatorZhang, Shaoqiang
dc.creatorYang, Yuanming
dc.creatorWang, Haiyan
dc.date.accessioned2020-06-23T12:10:21Z
dc.date.available2020-06-23T12:10:21Z
dc.date.issued2020
dc.description.abstractCOVID-19 is caused by SARS-CoV-2 which is a new enveloped virus that belongs to the Beta coronavirus genus. As a major health crisis, SARS-CoV-2 has infected over a million people around the world. There is currently no specific treatment available for patients with COVID-19 infection. Numerous potential therapies, including supportive intervention, immunomodulatory agents, antiviral therapy, and convalescent plasma transfusion, have been used in clinical practice. Herein, we summarize the current potential therapeutic approaches for diseases related to COVID-19 infection and discusses the clinical value of blood transfusion-related technologies used in COVID-19 treatment.pt_BR
dc.identifier.citationLI, Y. et al. Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies. Transfusion and Apheresis Science, [S.l.], 2020. No prelo.pt_BR
dc.identifier.urihttps://repositorio.ufla.br/handle/1/41535
dc.identifier.urihttp://www.sciencedirect.com/science/article/pii/S1473050220301427pt_BR
dc.languageen_USpt_BR
dc.publisherElsevierpt_BR
dc.rightsopenAccesspt_BR
dc.sourceTransfusion and Apheresis Sciencept_BR
dc.subjectCOVID-19pt_BR
dc.subjectConvalescent plasmapt_BR
dc.subjectPlasmapheresispt_BR
dc.subjectMesenchymal stem cellpt_BR
dc.titleCurrent treatment approaches for COVID-19 and the clinical value of transfusion-related technologiespt_BR
dc.typeArtigopt_BR

Arquivos

Licença do pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
953 B
Formato:
Item-specific license agreed upon to submission
Descrição: